Plain-English translation of NCT06799351 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This research study is looking at the connection between your gut bacteria and chemotherapy-related nerve damage (the tingling, numbness, and pain in your hands and feet that sometimes happens after cancer treatment). Researchers want to understand whether —a new treatment delivered through the rectum—helps reduce these symptoms, and whether changes in your gut bacteria might explain why some people improve and others don't. You would be part of a larger study where some people receive and others receive a placebo (inactive treatment), and researchers will analyze your stool samples to study your gut bacteria over time.
Nerve damage from chemotherapy is a common and painful side effect that often limits cancer treatment and hurts quality of life, yet there are few effective treatments available. This study exists because early evidence suggests might help, and scientists believe your gut bacteria could play an important role in how well the treatment works.
You likely qualify if…
You likely don't qualify if…
If you qualify, you would enroll in the main trial and receive either real or placebo (oxygen only) delivered through rectal insufflation—40 sessions over 16 weeks. You would also provide stool samples at the beginning and end of treatment so researchers can analyze your gut bacteria. During the 16-week period, you would complete questionnaires about your symptoms, quality of life, anxiety, and depression to track any improvements in your nerve damage and overall well-being.
AI-generated summary from trial data · Jun 1, 2026 · Not medical advice
Spain